Evidence map›Paper›PMID 40123596›Full record

ArticleJournal of oral microbiology2025

Impact of increased

Marta Kaminska, Noemie A M Dudzinska, Tülay Yucel-Lindberg, Birgitta Söder, Aswathy Narayanan, Jan Potempa, Piotr M Mydel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oral microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Virulence diversity amongJournal of oral microbiology · 2026
    Review
  3. Pathogenicity ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta KaminskaBroegelmann Research Laboratory, Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
Noemie A M DudzinskaBroegelmann Research Laboratory, Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
Tülay Yucel-LindbergDivision of Pediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-0129-8809
Birgitta SöderDivision of Periodontology, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
Aswathy NarayananDivision of Infectious Diseases, Department of Medicine Huddinge Karolinska Institutet, Stockholm, Sweden.
Jan PotempaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.ORCID https://orcid.org/0000-0002-3600-7461
Piotr M MydelBroegelmann Research Laboratory, Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.

Funding

Bacterial peptidylarginine deiminase, a link between gums and joint diseaseR01DE022597 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2023
$3.7M
NIDCR NIH HHS R01 DE022597
6 · The paper itself

Abstract

Background: Patients/Materials and Methods: We examined 56 CP patients and 36 healthy volunteers. Results: CP patients exhibited higher Conclusion: While the PPAD variant did not affect CP severity, it influenced oral microbiota composition. Further research is needed to understand citrullination's role in oral microbiota and chronic inflammatory disease development.

Indexed as

citrullinationmicrobiotaPeriodontitisPPADPPAD super-active variantPPAD-T2PPAD variant

Identifiers

PMID40123596
PMCPMC11926895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.